Sometimes, a paper comes along that is so revolutionary, it defies description. So rather than try to do justice to a recent paper in Parasitology Research, we’ll reproduce a few paragraphs here:
Blood has retracted a 2011 article by a now-deceased Stanford researcher, Holbrook Kohrt, who earlier this month lost two other papers over concerns about the whereabouts of the data.
The journal’s move comes about a week after Retraction Watch posted a story on the previous retractions, in the Journal of Clinical Investigation (JCI), of Kohrt’s work. As we noted then, Kohrt was a superstar young faculty member who died in 2016 of complications of hemophilia. He was the subject of this 2013 profile in the New York Times, which also wrote an obituary of him.
The Blood paper was titled “CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies.” The paper has been cited 148 times, according to Clarivate Analytics’ Web of Science.
The Journal of Clinical Investigation has retracted two papers from the lab of one of Stanford University’s most prominent cancer researchers over concerns about the integrity of the data.
The articles, published in 2012 and 2014, described work on ways of priming the immune system to enhance the activity of drugs to fight cancer.
The first author on the two articles was Holbrook “Brook” Kohrt, a superstar young faculty member who died in 2016 of complications of hemophilia. Kohrt was the subject of this 2013 profile in the New York Times, which also wrote an obituary of him.
The Journal of Biological Chemistry has retracted two papers by a Georgia State University researcher, as well as flagged eight more with expressions of concern, a move the scientist called “unfair and unjustified.”
Ming-Hui Zou, the common author on all ten papers — as well as on twomore that have been corrected by the same journal — is, according to Georgia State,
an internationally recognized researcher in molecular and translational medicine and a Georgia Research Alliance Eminent Scholar in Molecular Medicine and associate vice president for research at Georgia State University…
Here’s the retraction notice for “Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo,” published in 2008 Zou as the last author:
The American Journal of Public Health has retracted a controversial 2018 paper on the effects of economic austerity in Spain because it contained “inaccurate and misleading” results linking those policies to a massive spike in premature deaths.
The journal also has published a second piece, by a different group of authors, refuting the central claim of the now-retracted paper. Whereas the first article asserted that austerity in Spain during the mid-2000s led to more than 500,000 excess deaths, the new research says deaths in the country slowed during the country’s economic crisis.
The flawed article, “Austerity policies and mortality in Spain after the financial crisis of 2008,” was written by a group of researchers at the Hospital Universitario Nuestra Señora de Candelaria, in Santa Cruz de Tenerife, on the Canary Islands. The authors claimed that their analysis of the years 2011 to 2015 showed that:
Eight months after publishing a paper claiming that homeopathy can treat pain in rats, a Springer Nature journal is retracting the work.
The move follows swift criticism of the paper in Scientific Reports, which was written by researchers from India and the United Arab Emirates about the use of Toxicodendron pubescens, “popularly known as Rhus Tox (RT),” which “is recommended in alternative medicines as an anti-inflammatory and analgesic remedy.” The species is also commonly known as poison oak.
Nature has republished a paper on glacier melt that was retracted more than a year ago after the author became aware that he had made an error that underestimated such melt.
Hester Jiskoot, who had reviewed the paper for us for previous posts, and is now chief editor of the International Glaciological Society’s journals, told Retraction Watch this week that the episode
Ever wanted to hone your skills as a scientific sleuth? Now’s your chance.
Thanks to the American Society for Biochemistry and Molecular Biology (ASBMB), which is committed to educating authors on best practices in publishing, figure preparation, and reproducibility, we’re presenting the second in a series, Forensics Friday.
Take a look at the image below, and then take our poll. After that, click on the link below to find out the right answer.
While the presence of publication bias – the selective publishing of positive studies – in science is well known, debate continues about how extensive such bias truly is and the best way to identify it.
The most recent entrant in the debate is a paper by Robbie van Aert and co-authors, who have published a study titled “Publication bias examined in meta-analyses from psychology and medicine: A meta-meta-analysis” in PLoS ONE. Van Aert, a postdoc at the Meta-Research Center in the Department of Methodology and Statistics at Tilburg University, Netherlands, has been involved in the Open Science Collaboration’s psychology reproducibility project but has now turned his attention to understanding the extent of publication bias in the literature.
Using a sample of studies of psychology and medicine, the new “meta-meta-analysis” diverges from “previous research showing rather strong indications for publication bias” and instead suggests “only weak evidence for the prevalence of publication bias.” The analysis found mild publication bias influences psychology and medicine similarly.
Retraction Watch asked van Aert about his study’s findings. His answers have been lightly edited for clarity and length.
RW: How much are empiric analyses of publication bias influenced by the methods used? Based on your work, do you believe there is a preferred method to look at bias?
Science is retracting a 2017 paper about the deadly Kumamoto earthquake about a month after the university announced that the paper’s first author, Aiming Lin, had committed misconduct, including falsification of data and plagiarism.
Science editor in chief Jeremy Berg told us in late March that the journal had been trying to obtain more information in preparation for writing an expression of concern. Here’s today’s retraction notice: